Case Studies

Developing a pharmacy submission pack for a reproduction biosimilar in the UK

26/04/2023

Author:

Sarah Bailey

About the Author

Article Tags

Biosimilars HTA HTA Process Launch Pricing

Share this article

Related articles

Articles

03.11.2025

Designing Payer-Ready Trials in 2025: Five Decisio...

Clinical innovation has never moved faster. Tools like single-arm designs, novel surrogates, and ada...

Poster

15.10.2025

What Are the Likely PICOs for Tovorafenib and Lifi...

Objectives: EUHTA regulation has applied from the 1st January 2025 for oncology pr...